Core Insights - Phreesia Inc. is a healthcare technology company focused on patient intake management solutions, aiming to enhance efficiency and patient experience in a competitive landscape [1] Financial Performance - On December 8, 2025, Phreesia reported earnings per share (EPS) of $0.07, which was below the estimated $0.24, indicating profitability challenges [2][6] - The company generated revenue of approximately $120.3 million, missing the estimated $132.5 million, suggesting difficulties in achieving sales targets [3][6] - Analysts had anticipated earnings of 2 cents per share on revenue of $120.05 million, indicating that actual revenue was slightly above these expectations but still below broader market estimates [3] Financial Ratios - The price-to-sales ratio is about 2.60, suggesting investors are willing to pay $2.60 for every dollar of sales [4] - The enterprise value to sales ratio is approximately 2.38, indicating the company's valuation relative to its revenue [4] - Phreesia has a low debt-to-equity ratio of about 0.01, suggesting minimal reliance on debt financing [5] - The current ratio of approximately 2.44 indicates a strong ability to cover short-term liabilities with short-term assets, reflecting solid liquidity [5]

Group 1 - The article does not provide any relevant content regarding company or industry insights [1]

Core Insights - Phreesia reported revenue of $120.33 million for the quarter ended October 2025, reflecting a year-over-year increase of 12.7% and a slight revenue surprise of +0.17% over the Zacks Consensus Estimate of $120.13 million [1] - The company's EPS for the quarter was $0.10, a significant improvement from -$0.25 in the same quarter last year, although it did not deliver an EPS surprise against the consensus estimate of $0 [1] Financial Performance Metrics - Average healthcare services clients were reported at 4,520, slightly below the estimated 4,530 [4] - Patient payment volume reached $1.18 billion, exceeding the estimated $1.16 billion [4] - Payment facilitator volume percentage was 85%, surpassing the average estimate of 81.3% [4] - Revenue from subscription and related services was $55.48 million, slightly above the estimated $55.44 million, with a year-over-year change of +12.4% [4] - Revenue from network solutions was $37.43 million, close to the estimated $37.46 million, showing a year-over-year increase of +14.4% [4] - Revenue from payment processing fees was $27.42 million, exceeding the estimated $27.25 million, representing an 11% increase compared to the previous year [4] Stock Performance - Over the past month, Phreesia's shares have returned -7.9%, contrasting with the Zacks S&P 500 composite's +1.2% change [3] - The stock currently holds a Zacks Rank 2 (Buy), indicating potential for outperformance in the near term [3]

Financial Data and Key Metrics Changes - Total revenue for Q3 Fiscal 2026 was $120.3 million, representing a 13% year-over-year increase [12] - Adjusted EBITDA reached $29.1 million, an increase of $19 million year-over-year and $7 million quarter-over-quarter, with an all-time high adjusted EBITDA margin of 24% [12][13] - Net income was $4.3 million, marking the second consecutive quarter of positive net income [14] - Cash and cash equivalents at the end of the quarter were $106.4 million, up from $98.3 million in the prior quarter [15] Business Line Data and Key Metrics Changes - Average Healthcare Services Clients (AHSCs) increased to 4,520, up by 53 from the prior quarter, with expectations to reach 4,500 for the full fiscal year [13] - Total revenue per AHSC was $26,622, a 6% increase year-over-year [14] Market Data and Key Metrics Changes - The company expects to add approximately 80 AHSCs annually through the AccessOne acquisition, which manages a portfolio of approximately $450 million [17] - AccessOne's blended take rate averages 4%-12% on its managed portfolio, depending on the provider type and program mix [17] Company Strategy and Development Direction - The company is focusing on provider financing and healthcare provider marketing as new growth areas, aiming to enhance stakeholder value [7][8] - The acquisition of AccessOne is seen as a significant growth lever, addressing the financial risks faced by healthcare providers due to rising patient financial responsibility [8][10] - The company aims to leverage its existing relationships and infrastructure to participate in the multi-billion dollar healthcare provider marketing opportunity [9][10] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in the growth potential of AccessOne and plans to invest in its go-to-market strategy [24][25] - The updated revenue outlook for fiscal 2026 is projected to be between $479 million and $481 million, reflecting contributions from AccessOne [18] - For fiscal 2027, the company anticipates revenue in the range of $545 million to $559 million, with AccessOne contributing approximately 6.5% [21] Other Important Information - The company has achieved positive operating cash flow and free cash flow for five consecutive quarters [15] - The AccessOne acquisition was funded with approximately $53 million in cash and a $110 million secured bridge loan [16] Q&A Session Summary Question: Growth potential for AccessOne - Management indicated that AccessOne's product needs investment before it can be offered to the majority of existing clients, with plans to invest in go-to-market strategies [24][25] Question: Financing and loan refinancing - Management is actively looking to replace the bridge loan and is confident in the demand for financing options [29] Question: AHSC growth strategy - Management highlighted that the provider side is seeing strong demand for intake and AI offerings, while Network Solutions and new offerings are expected to drive growth [30] Question: Core organic growth expectations - Management expects core organic growth to be in the mid-single-digit percentage range for fiscal 2027, with Network Solutions anticipated to grow the fastest [32][34] Question: HCP marketing initiative - Management confirmed that they have started selling the HCP marketing offering to select clients and expect it to generate incremental revenue [41] Question: Updated guidance concerns - Management clarified that the updated guidance reflects a more measured approach to Network Solutions due to market fluidity [43][46] Question: AccessOne's funded and unfunded models - Management emphasized AccessOne's flexibility in offering various funding models to meet client needs and expected to learn which offerings resonate best with clients [50] Question: DTC advertising impact - Management acknowledged that political issues around DTC advertising contribute to market fluidity but expressed confidence in their long-term positioning [54][56] Question: MediFind's competitive advantages - Management highlighted MediFind's focus on connecting patients with the right specialists without the need for paid leads, enhancing its competitive position [62]

Financial Data and Key Metrics Changes - Total revenue for Q3 Fiscal 2026 was $120.3 million, representing a 13% year-over-year increase [12] - Adjusted EBITDA reached $29.1 million, an increase of $19 million year-over-year and $7 million quarter-over-quarter, with an all-time high adjusted EBITDA margin of 24% [12][13] - Net income was $4.3 million, marking the second consecutive quarter of positive net income [14] - Cash and cash equivalents at the end of the quarter were $106.4 million, up from $98.3 million in the prior quarter [15] Business Line Data and Key Metrics Changes - Average healthcare services clients (AHSCs) increased to 4,520, up by 53 from the prior quarter, with expectations to reach 4,500 for the full fiscal year [13] - Total revenue per AHSC was $26,622, a 6% year-over-year increase, reflecting a return to levels last seen in Q3 Fiscal 2022 [14] Market Data and Key Metrics Changes - The company is expanding into the provider financing market through the acquisition of AccessOne, which is expected to add approximately 80 AHSCs annually [17] - The healthcare provider marketing initiative is positioned to tap into a multi-billion dollar market opportunity [10] Company Strategy and Development Direction - The company aims to enhance stakeholder value through emerging products, particularly in provider financing and healthcare provider marketing [7][8] - The acquisition of AccessOne is seen as a significant growth lever, addressing the financial risks faced by healthcare providers due to rising patient financial responsibility [8][17] - The strategy includes leveraging existing relationships and infrastructure to engage both patients and healthcare providers effectively [10][11] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in the growth potential of AccessOne and plans to invest in its go-to-market strategy [24][25] - The updated revenue outlook for Fiscal 2026 is projected to be between $479 million and $481 million, with adjusted EBITDA expected to range from $99 million to $101 million [18][19] - For Fiscal 2027, revenue is anticipated to be between $545 million and $559 million, with adjusted EBITDA expected to be between $125 million and $135 million [21] Other Important Information - The company has achieved positive operating cash flow and free cash flow for five consecutive quarters [15] - The AccessOne acquisition was funded with approximately $53 million in cash and a $110 million secured bridge loan [16] Q&A Session Summary Question: Growth potential for AccessOne - Management indicated that the product needs further investment before it can be offered to the majority of existing clients, with plans to invest in go-to-market strategies [24] Question: Financing and market conditions - Management is actively looking to refinance the bridge loan and is optimistic about the demand in the marketplace [29] Question: Core growth expectations for Fiscal 2027 - Management expects mid-single-digit growth in AHSCs, with network solutions anticipated to grow the fastest [32][34] Question: HCP marketing initiative - The company has started selling the HCP marketing offering to select clients, expecting it to generate incremental revenue [40][41] Question: Updated guidance concerns - Management clarified that the updated guidance reflects a more measured approach to network solutions due to market fluidity [43][46] Question: AccessOne's offerings and demand - Management highlighted AccessOne's flexibility in offering various funding models to meet client needs, with expectations for growth in the coming years [50] Question: Share buyback considerations - Management acknowledged the consideration of a share buyback program but emphasized the priority of debt repayment and investment opportunities [80]

Financial Data and Key Metrics Changes - Total revenue for Q3 Fiscal 2026 was $120.3 million, representing a 13% year-over-year increase [11] - Adjusted EBITDA reached $29.1 million, an increase of $19 million year-over-year and $7 million quarter-over-quarter, with an all-time high adjusted EBITDA margin of 24% [11] - Net income was $4.3 million, marking the second consecutive quarter of positive net income [12] - Cash and cash equivalents at the end of the quarter were $106.4 million, up from $98.3 million in the prior quarter [14] - Operating cash flow was $15.5 million, up $9.7 million year-over-year, and free cash flow was $8.8 million, up $7.2 million year-over-year [14] Business Line Data and Key Metrics Changes - Average healthcare services clients (AHSCs) increased to 4,520, up by 53 from the prior quarter [11] - Total revenue per AHSC was $26,622, a 6% increase year-over-year [12] Market Data and Key Metrics Changes - The company expects to add approximately 80 AHSCs annually through the AccessOne acquisition, which manages a portfolio of approximately $450 million [16] - The blended take rate for AccessOne's managed portfolio averages 4%-12% depending on the provider type and program mix [16] Company Strategy and Development Direction - The company is focusing on provider financing and healthcare provider marketing as new growth areas [6][8] - The acquisition of AccessOne is seen as a significant growth lever to enhance cash flow for healthcare providers [8] - The company aims to leverage its existing relationships and infrastructure to engage healthcare providers and life sciences partners effectively [9] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in sustaining growth and enhancing stakeholder value through emerging products [5] - The updated revenue outlook for fiscal 2026 is projected to be between $479 million and $481 million, reflecting a contribution from AccessOne [17] - For fiscal 2027, the company anticipates revenue in the range of $545 million to $559 million, with adjusted EBITDA expected to be between $125 million and $135 million [19] Other Important Information - The company has achieved positive operating cash flow and free cash flow for five consecutive quarters [14] - The AccessOne acquisition was funded with approximately $53 million in cash and a $110 million secured bridge loan [15] Q&A Session Summary Question: Growth potential for AccessOne - Management indicated that AccessOne's product needs investment before it can be offered to the majority of existing clients, with plans to invest in go-to-market strategies [22][23] Question: Financing and market conditions - Management is actively looking to refinance the bridge loan and is optimistic about market demand for financing solutions [26][27] Question: Core growth expectations for fiscal 2027 - Management expects network solutions to grow the fastest, followed by payment processing and subscription services [31][32] Question: HCP marketing initiative - The company has started selling the HCP marketing offering to select clients and anticipates it will generate incremental revenue [39][40] Question: Updated fiscal 2026 guidance - Management clarified that the updated guidance reflects a more measured approach to network solutions due to market fluidity [42][45] Question: AccessOne's funded and unfunded models - Management highlighted AccessOne's flexibility in offering various funding models to meet client needs and expects to learn which offerings resonate best over time [47][49]

To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh. ...

Acquisition - Phreesia acquired AccessOne for $160 million in cash, funded by a mix of cash and debt [11, 12] - The acquisition extends Phreesia's reach into provider financing, addressing a $74 billion market [13, 15] - AccessOne's results are not included in the Q3 FY2026 presentation [6] Financial Performance - Total revenue for Q3 FY2026 was $120 million, a 13% year-over-year increase [19] - Adjusted EBITDA for Q3 FY2026 was $29 million, a 198% year-over-year increase [19] - Total revenue per AHSC for Q3 FY2026 was $26600, a 6% year-over-year increase [19] Outlook - FY2026 total revenue is projected to be between $479 million and $481 million, with Adjusted EBITDA between $99 million and $101 million [51] - The company anticipates approximately 4515 AHSCs for FY2026 [51] - FY2027 total revenue is projected to be between $545 million and $559 million, with Adjusted EBITDA between $125 million and $135 million [53, 54]

ALL-REMOTE COMPANY/WILMINGTON, Del.--(BUSINESS WIRE)--Phreesia, Inc. (NYSE: PHR) ("Phreesia†or the "Company") announced financial results today for the fiscal third quarter ended October 31, 2025. "I am very proud of our team's strong execution in the fiscal third quarter, which is reflected throughout this letter from our revenue and profit results to product updates and client stories,†said CEO and Co- Founder Chaim Indig. Please visit the Phreesia investor relations website at ir.phreesia.com to view the ...

Financial Performance - Total revenue for Q3 Fiscal 2026 was $120.3 million, representing a 13% year-over-year increase[7] - Net income for the quarter was $4.3 million, compared to a net loss of $14.4 million in the same period last year[7] - Adjusted EBITDA for the quarter was $29.1 million, compared to $9.8 million in the same period last year[7] - Total revenues for the three months ended October 31, 2025, were $120.3 million, a 12.5% increase from $106.8 million in the same period of 2024[28] - Net income for the three months ended October 31, 2025, was $4.3 million, compared to a net loss of $14.4 million in the same period of 2024[28] - Operating income improved to $3.7 million from a loss of $13.8 million year-over-year[28] - Adjusted EBITDA for the three months ended October 31, 2025, was $29,149,000, compared to $9,769,000 for the same period in 2024, representing a significant increase[41] - Free cash flow for the three months ended October 31, 2025, was $8,801,000, compared to $1,603,000 for the same period in 2024, demonstrating improved cash generation capabilities[44] - Net income for the three months ended October 31, 2025, was $4,271,000, a significant improvement from a net loss of $14,403,000 in the same period of 2024[41] Client Metrics - Average number of healthcare services clients (AHSCs) increased to 4,520, up 7% year-over-year[7] - The company expects AHSCs for fiscal 2026 to be approximately 4,515, including 15 AHSCs from the AccessOne acquisition[12] - The average number of healthcare services clients (AHSCs) increased to 4,520 in the three months ended October 31, 2025, up from 4,237 in the same period of 2024, indicating growth in client acquisition[48] - Total revenue per AHSC for the three months ended October 31, 2025, was $26,622, compared to $25,207 for the same period in 2024, reflecting a year-over-year increase of 5.6%[48] Revenue Outlook - The company updated its revenue outlook for fiscal 2026 to a range of $479 million to $481 million, including approximately $7.5 million from AccessOne[10] - For fiscal 2027, the company anticipates revenue in the range of $545 million to $559 million, a 14-16% increase over fiscal 2026[13] Acquisition and Investment - The AccessOne acquisition was completed for approximately $160 million, enhancing the company's financing solutions for healthcare receivables[4] - Research and development expenses were $29.5 million, consistent with $29.3 million in the prior year, indicating stable investment in innovation[28] - Capitalized internal-use software development costs for the three months ended October 31, 2025, were $3,395,000, compared to $3,566,000 in the same period of 2024, indicating a stable investment in technology[44] Cash and Assets - Cash and cash equivalents as of October 31, 2025, were $106.4 million, an increase of $22.2 million from January 31, 2025[7] - Cash and cash equivalents increased to $106.4 million as of October 31, 2025, compared to $81.7 million at the end of the previous year[32] - Total current assets rose to $240.9 million, a 18.5% increase from $203.3 million as of January 31, 2025[26] Liabilities and Expenses - Total liabilities decreased to $103.1 million from $123.6 million, reflecting a reduction of 16.6%[26] - GAAP operating expenses for the three months ended October 31, 2025, totaled $89,427,000, down from $96,873,000 in the same period of 2024, indicating cost management efforts[46] - Stock-based compensation expense for the three months ended October 31, 2025, was $15,959,000, slightly lower than $16,525,000 in the same period of 2024, reflecting a controlled approach to compensation[46] Payment Metrics - Patient payment volume reached $1,181 million in the three months ended October 31, 2025, compared to $1,081 million in the same period of 2024, showing a growth of 9.3%[51] - The payment facilitator volume percentage increased to 85% in the three months ended October 31, 2025, up from 81% in the same period of 2024, indicating a higher reliance on the payment facilitation services[51]